Search stocks

Find any stock by ticker or company name

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Избранное
Рынки
Календарь
Скринер
Новости
О нас

BWXT - BWX Technologies, Inc. Последние новости | Finranks

Home

/

BWXT

B

BWX Technologies, Inc. (BWXT)

NYQ – Цена в реальном времени. Валюта: USD

170.44

+0.73 (0.43%)

Рынок открыт: Aug 12, 2026, 12:54 PM EDT

170.00

+0.29 (0.17%)

Предыдущая сессия: Aug 11, 2026, 7:59 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

BWX Technologies: Fundamentals Are Good But Valuation Is Expensive

BWX Technologies: Fundamentals Are Good But Valuation Is Expensive

BWX Technologies (BWXT) earns a hold rating due to strong fundamentals but limited upside at current valuation. Naval business provides multi-year revenue visibility, supported by a $6.93 billion Government Operations backlog. Commercial Operations offers growth potential, with 39% organic revenue growth in Q1 2026 and margin expansion opportunities.

Unlocking $50 Billion Across the Nuclear Value Chain

Unlocking $50 Billion Across the Nuclear Value Chain

The Department of Energy (DOE) has narrowed the competition for its proposed Nuclear Lifecycle Innovation Campuses (NLICs) to five states: Utah, Tennessee, Oklahoma, Louisiana, and Idaho. The selection advances an effort that could create new investment and contracting opportunities across nearly every part of the nuclear value chain.

Advance Auto Parts vs. BWX Technologies: Is an Auto Parts Retailer or a Nuclear Energy Pioneer the Better Buy in 2026?

Advance Auto Parts vs. BWX Technologies: Is an Auto Parts Retailer or a Nuclear Energy Pioneer the Better Buy in 2026?

Advance Auto Parts is executing a major restructuring plan to streamline its supply chain and enhance store efficiency. BWX Technologies maintains a dominant position in the nuclear propulsion market with a massive revenue backlog from government contracts.

3 Nuclear Energy Stocks Powering the AI Boom in August

3 Nuclear Energy Stocks Powering the AI Boom in August

Artificial intelligence has an electricity problem, and nuclear is the answer investors keep circling back to.

BWXT Q2 Earnings Call Centers on Higher Outlook and Nuclear Focus

BWXT Q2 Earnings Call Centers on Higher Outlook and Nuclear Focus

BWXT raises its 2026 outlook as stronger operations support higher guidance, while a medical divestiture and PCG deal sharpen its nuclear focus.

BWX Technologies, Inc. (BWXT) Q2 2026 Earnings Call Transcript

BWX Technologies, Inc. (BWXT) Q2 2026 Earnings Call Transcript

BWX Technologies, Inc. (BWXT) Q2 2026 Earnings Call Transcript

BWX Technologies Q2 Earnings Call Highlights

BWX Technologies Q2 Earnings Call Highlights

BWX Technologies NYSE: BWXT reported second-quarter 2026 revenue growth of 18% and raised its full-year financial outlook, citing continued demand across nuclear national security and commercial power markets.

Видео

No Data

There is no data to display

Пресс-релизы

BWX Technologies Reports Second Quarter 2026 Results

BWX Technologies Reports Second Quarter 2026 Results

LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported second quarter 2026 results. A reconciliation of non-GAAP results is detailed in Exhibit 1. “We had strong second quarter 2026 results that were ahead of our expectations,” said Rex. D. Geveden, president and chief executive officer. “Once again we saw strong execution across our business, high growth in Commercial Operations, and good free cash flow generation.” “Demand for new n.

BWXT Selling Medical Business to Nordic Capital in Transaction Valued at up to $800 Million

BWXT Selling Medical Business to Nordic Capital in Transaction Valued at up to $800 Million

LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) announced today it has entered into a definitive agreement to sell its medical business to Nordic Capital, an experienced healthcare investor with broad expertise and a deep understanding of the radiopharmaceutical industry and its value chain. The transaction, valued at up to $800 million, includes BWXT Medical and Kinectrics' stable medical isotopes business. The sale will enable BWXT to concentrate resources and capital on.